Hvid H, Brand CL, Hummelshoj T, Jensen S, et al. Preclinical exploration of combined glucagon inhibition and liver-preferential insulin for treatment of diabetes using in vitro assays and rat and mouse models. Diabetologia 2022 Nov 21. doi: 10.1007/s00125-022-05828.
PMID: 36404376